Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jun 23, 2026
Reporting period
Not applicable
Filed with the SEC
Jun 25, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001104659-26-077777
Filed / recorded
Jun 25, 2026, 8:19 PM UTC
Added to OQRO
Oct 8, 2026, 12:54 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Orchestra BioMed Holdings, Inc.
Issuer CIK
1814114
Ticker
OBIO
Reporting person
Chris Cleary
Relationship
Director
Security
Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
Jun 23, 2026
Transaction code
A
Shares / units
42,553
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
42,553
Ownership form
Direct
Amendment
No
Footnotes from the filing
The stock options will vest on the one year anniversary of June 23rd, 2026 (the "Grant Date"), subject to the Reporting Person's continuous service through such date.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.